Accelerated Hypofractionated Magnetic Resonance Guided Adaptive Radiation Therapy for Ultracentral Lung Tumors.

"Conflicts of Interest ALR: Received travel/reimbursement from GT Medical Technologies. KM: Reports ownership interest in a company that provides consulting services on image guided radiation therapy technology (MR Guidance, LLC. Gainesville, FL, USA). She received travel reimbursement/consulting fees/speaking fees/grants from ViewRay Inc. NB: grants from ViewRay Inc. MDC: Honoraria from ViewRay, Sirtex, IBA and institutional research funding from ViewRay, Novocure, StratPharma TK: Received travel/reimbursement from GT Medical Technologies. MDH: Proton Collaborative Group Executive Committee institutional representative and voting member, Miami Cancer Institute (unpaid); grant funding from Live Like Bella Pediatric Cancer Research Initiative, Florida Department of Health grants 8LA04 and 22L01. ANG: Honoraria from ViewRay, Inc., Elekta AB, IBA AB. Ownership interest of Atlantic Health Solutions (uPlan™) MPM: Consulting Fees from Karyopharm, Kazia Therapeutics, Sapience, Zap, Mevion, Xoft; BOD Oncoceutics; Stock in Chimerix RK: Honoraria from Accuray Inc., Elekta AB, ViewRay Inc., Novocure Inc., Elsevier Inc., Brainlab, Kazia Therapeutics, Castle Biosciences, and institutional research funding from Medtronic Inc., Blue Earth Diagnostics Ltd., Novocure Inc., GT Medical Technologies, AstraZeneca, Exelixis, ViewRay Inc., Brainlab, Cantex Pharmaceuticals, and Kazia Therapeutics. All remaining authors declare no conflicts of interest."

"This research received no external funding."